-+ 0.00%
-+ 0.00%
-+ 0.00%

Amneal Pharmaceuticals Expects To Meet Its Net Revenue, Adjusted EBITDA, And Adjusted EPS Guidance, Exceed Its Operating Cash Flow Guidance - Filing

Benzinga·01/15/2025 11:17:14
Listen to the news

The Company expects to meet its net revenue, adjusted EBITDA, and adjusted diluted EPS guidance, exceed its operating cash flow guidance, and exceed (incur less than) its capital expenditures guidance. The Company also intends to announce that it estimates its net leverage as of December 31, 2024 to be approximately 4x.